Perceptions and Practice of Urologists in Saudi Arabia Regarding Sexual Complications Related to LUTS/BPH Management.

IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Saad Alshahrani, Abdulrahman Binsaleh, Ahmed Othman Alghamdi, Saad Alqasem, Ali Al-Gonaim, Ashraf El-Metwally
{"title":"Perceptions and Practice of Urologists in Saudi Arabia Regarding Sexual Complications Related to LUTS/BPH Management.","authors":"Saad Alshahrani, Abdulrahman Binsaleh, Ahmed Othman Alghamdi, Saad Alqasem, Ali Al-Gonaim, Ashraf El-Metwally","doi":"10.3390/jcm14124367","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objectives</b>: This study aimed to evaluate perceptions and practices of urologists in Saudi Arabia regarding discussions of erectile dysfunction (ED) and ejaculatory dysfunction (EjD) with patients before initiating BPH treatments. <b>Methods</b>: A cross-sectional survey was conducted using a structured questionnaire distributed during the 36th Saudi Urological Annual Conference held in Riyadh in February 2025 among urologists in Saudi Arabia. A binary outcome variable, \"frequent and open discussion,\" was created based on a scoring system using the median score of these responses. Data analysis included descriptive statistics and univariate (<i>p</i> < 0.25) and multivariate (<i>p</i> < 0.05) logistic regression using SPSS version 27. <b>Results</b>: Discussions about ED risks were most frequent before prescribing 5-alpha reductase inhibitors (5-ARIs) (51.3%) and combined alpha-blockers and 5-ARIs therapy (50.0%), whereas EjD risks were more frequently addressed before alpha-blocker monotherapy (59.2%) and transurethral resection of the prostate (TURP) (56.6%). A substantial proportion of urologists discussed alternative treatments based on sexual dysfunction risks, particularly before TURP (53.9%), alpha-blockers (47.4%), and 5-ARIs (43.4%). Univariate analysis revealed a trend towards more open discussions among non-Saudi urologists (OR 4.58, 95% CI 0.88-23.74, <i>p</i> = 0.06) and a significant association with working in private hospitals (OR 3.68, 95% CI 0.39-35.14, <i>p</i> = 0.03). However, these associations did not hold in multivariate analysis. <b>Conclusions</b>: Urologists in Saudi Arabia demonstrate variability in discussing sexual complications with patients before BPH treatments. Consistent and comprehensive discussions about ED and EjD risks are crucial for informed patient decision-making. Standardized guidelines and educational programs are needed to enhance urologists' communication skills and ensure consistent patient counseling.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"14 12","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12194723/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jcm14124367","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: This study aimed to evaluate perceptions and practices of urologists in Saudi Arabia regarding discussions of erectile dysfunction (ED) and ejaculatory dysfunction (EjD) with patients before initiating BPH treatments. Methods: A cross-sectional survey was conducted using a structured questionnaire distributed during the 36th Saudi Urological Annual Conference held in Riyadh in February 2025 among urologists in Saudi Arabia. A binary outcome variable, "frequent and open discussion," was created based on a scoring system using the median score of these responses. Data analysis included descriptive statistics and univariate (p < 0.25) and multivariate (p < 0.05) logistic regression using SPSS version 27. Results: Discussions about ED risks were most frequent before prescribing 5-alpha reductase inhibitors (5-ARIs) (51.3%) and combined alpha-blockers and 5-ARIs therapy (50.0%), whereas EjD risks were more frequently addressed before alpha-blocker monotherapy (59.2%) and transurethral resection of the prostate (TURP) (56.6%). A substantial proportion of urologists discussed alternative treatments based on sexual dysfunction risks, particularly before TURP (53.9%), alpha-blockers (47.4%), and 5-ARIs (43.4%). Univariate analysis revealed a trend towards more open discussions among non-Saudi urologists (OR 4.58, 95% CI 0.88-23.74, p = 0.06) and a significant association with working in private hospitals (OR 3.68, 95% CI 0.39-35.14, p = 0.03). However, these associations did not hold in multivariate analysis. Conclusions: Urologists in Saudi Arabia demonstrate variability in discussing sexual complications with patients before BPH treatments. Consistent and comprehensive discussions about ED and EjD risks are crucial for informed patient decision-making. Standardized guidelines and educational programs are needed to enhance urologists' communication skills and ensure consistent patient counseling.

沙特阿拉伯泌尿科医生对LUTS/BPH管理相关的性并发症的看法和实践。
目的:本研究旨在评估沙特阿拉伯泌尿科医生在开始前列腺增生治疗前与患者讨论勃起功能障碍(ED)和射精功能障碍(EjD)的看法和做法。方法:在2025年2月在利雅得举行的第36届沙特泌尿外科年会上,对沙特泌尿科医生进行了一项横断面调查,使用了一份结构化问卷。一个二元结果变量“频繁和开放的讨论”是基于使用这些回答的中位数得分的评分系统创建的。数据分析采用描述性统计及单因素(p < 0.25)和多因素(p < 0.05) logistic回归,采用SPSS version 27。结果:在处方5- α还原酶抑制剂(5-ARIs)(51.3%)和α受体阻滞剂与5-ARIs联合治疗(50.0%)之前,讨论ED风险的频率最高,而在α受体阻滞剂单药治疗(59.2%)和经尿道前列腺切除术(56.6%)之前,讨论EjD风险的频率更高。相当大比例的泌尿科医生讨论了基于性功能障碍风险的替代治疗,特别是在TURP (53.9%), α受体阻滞剂(47.4%)和5-ARIs(43.4%)之前。单因素分析显示,非沙特泌尿科医生更倾向于公开讨论(OR 4.58, 95% CI 0.88-23.74, p = 0.06),且与在私立医院工作有显著关联(OR 3.68, 95% CI 0.39-35.14, p = 0.03)。然而,这些关联在多变量分析中并不成立。结论:沙特阿拉伯的泌尿科医生在前列腺增生症治疗前与患者讨论性并发症方面表现出差异。关于ED和EjD风险的一致和全面的讨论对于知情的患者决策至关重要。需要标准化的指导方针和教育计划来提高泌尿科医生的沟通技巧,并确保一致的患者咨询。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Medicine
Journal of Clinical Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
5.70
自引率
7.70%
发文量
6468
审稿时长
16.32 days
期刊介绍: Journal of Clinical Medicine (ISSN 2077-0383), is an international scientific open access journal, providing a platform for advances in health care/clinical practices, the study of direct observation of patients and general medical research. This multi-disciplinary journal is aimed at a wide audience of medical researchers and healthcare professionals. Unique features of this journal: manuscripts regarding original research and ideas will be particularly welcomed.JCM also accepts reviews, communications, and short notes. There is no limit to publication length: our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信